BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 30541574)

  • 1. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
    Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
    Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
    Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.
    Dewangan J; Srivastava S; Mishra S; Divakar A; Kumar S; Rath SK
    Biochem Pharmacol; 2019 Jun; 164():326-335. PubMed ID: 31028743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
    Roy R; Dagher A; Butterfield C; Moses MA
    Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
    Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
    Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
    Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D
    Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α.
    Wu Z; Cai X; Huang C; Xu J; Liu A
    Oncol Rep; 2016 Mar; 35(3):1696-702. PubMed ID: 26718330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Hydroxynonenal promotes growth and angiogenesis of breast cancer cells through HIF-1α stabilization.
    Li YP; Tian FG; Shi PC; Guo LY; Wu HM; Chen RQ; Xue JM
    Asian Pac J Cancer Prev; 2014; 15(23):10151-6. PubMed ID: 25556440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade.
    Ciccone V; Terzuoli E; Ristori E; Filippelli A; Ziche M; Morbidelli L; Donnini S
    Int J Mol Med; 2022 Jul; 50(1):. PubMed ID: 35656893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of HIF-1
    Schoos A; Gabriel C; Knab VM; Fux DA
    J Pharmacol Exp Ther; 2019 Sep; 370(3):480-489. PubMed ID: 31300611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.
    Ma J; Xue Y; Cui W; Li Y; Zhao Q; Ye W; Zheng J; Cheng Y; Ma Y; Li S; Han T; Miao L; Yao L; Zhang J; Liu W
    Cancer; 2012 Sep; 118(17):4105-16. PubMed ID: 22907703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.